Trial intelligence / Profile preview

Liposoluble vitamin status in patients on long-term octreotide

NL-OMON32903Not yet recruiting

Sponsor
University Medical Center Groningen
Start
Dec 2008
Modality
Peptides
Countries
1
01

Overview

Open-label, single-arm trial of octreotide in acromegaly and apudoma (NET), sponsored by University Medical Center Groningen. Primary endpoints: Fat-soluble vitamin status, Relevant lipid components and 1 more. Planned start Dec 2008; status: not yet recruiting.

02

Drugs

octreotide
03

Conditions

acromegalyapudoma (NET)

Beyond the preview

Go deeper on NL-OMON32903.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32903.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call